ArticleAmerican journal of cancer research2025

Key prognostic factors in transarterial chemoembolization combined with sorafenib treatment for hepatocellular carcinoma with portal vein tumor thrombosis.

Zilun Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.